152 related articles for article (PubMed ID: 9178675)
1. Genetic markers may predict disease behavior in patients with ulcerative colitis.
Roussomoustakaki M; Satsangi J; Welsh K; Louis E; Fanning G; Targan S; Landers C; Jewell DP
Gastroenterology; 1997 Jun; 112(6):1845-53. PubMed ID: 9178675
[TBL] [Abstract][Full Text] [Related]
2. Genetic heterogeneity within ulcerative colitis determined by an interleukin-1 receptor antagonist gene polymorphism and antineutrophil cytoplasmic antibodies.
Papo M; Quer JC; Gutierrez C; Broch M; Casellas F; Pastor RM; Olona M; Richart C
Eur J Gastroenterol Hepatol; 1999 Apr; 11(4):413-20. PubMed ID: 10321759
[TBL] [Abstract][Full Text] [Related]
3. Evidence of genetic heterogeneity in IBD: 1. The interleukin-1 receptor antagonist in the predisposition to suffer from ulcerative colitis.
Bioque G; Bouma G; Crusius JB; Koutroubakis I; Kostense PJ; Meuwissen SG; Peña AS
Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):105-10. PubMed ID: 8723412
[TBL] [Abstract][Full Text] [Related]
4. Lack of association between HLA-DRB1 alleles of the major histocompatibility complex and p-ANCA status or clinical characteristics in patients with ulcerative colitis.
Folwaczny C; Zahn R; Brünnler G; Albert E; Koenig A; Noehl N; Loeschke K; Fricke H
Z Gastroenterol; 1999 Feb; 37(2):133-40. PubMed ID: 10190246
[TBL] [Abstract][Full Text] [Related]
5. Association of the HLA-DRB1*0701 allele with perinuclear anti-neutrophil cytoplasmatic antibodies in Mexican patients with severe ulcerative colitis.
Yamamoto-Furusho JK; Uscanga-Domínguez L; Lopez-Martinez A; Granados J
World J Gastroenterol; 2006 Mar; 12(10):1617-20. PubMed ID: 16570357
[TBL] [Abstract][Full Text] [Related]
6. Association of HLA-DRB1 alleles and anti-neutrophil cytoplasmic antibodies in Han and Uyghur patients with ulcerative colitis in China.
Gao F; Aheman A; Lu JJ; Abuduhadeer M; Li YX; Kuerbanjiang A
J Dig Dis; 2014 Jun; 15(6):299-305. PubMed ID: 24597629
[TBL] [Abstract][Full Text] [Related]
7. Genetic and immunological markers in pouchitis.
Brett PM; Yasuda N; Yiannakou JY; Herbst F; Ellis HJ; Vaughan R; Nicholls RJ; Ciclitira PJ
Eur J Gastroenterol Hepatol; 1996 Oct; 8(10):951-5. PubMed ID: 8930557
[TBL] [Abstract][Full Text] [Related]
8. Genetic markers in clinically well defined patients with ulcerative colitis (UC).
Bouma G; Crusius JB; García-González MA; Meijer BU; Hellemans HP; Hakvoort RJ; Schreuder GM; Kostense PJ; Meuwissen SG; Peña AS
Clin Exp Immunol; 1999 Feb; 115(2):294-300. PubMed ID: 9933456
[TBL] [Abstract][Full Text] [Related]
9. [Interleukin (IL)-1beta, IL-1 receptor antagonist and IL-4 gene polymorphisms in ulcerative colitis in the Chinese].
Peng Z; Hu P; Cui Y; Li C
Zhonghua Nei Ke Za Zhi; 2002 Apr; 41(4):248-51. PubMed ID: 12133437
[TBL] [Abstract][Full Text] [Related]
10. Molecularly defined HLA-DR2 alleles in ulcerative colitis and an antineutrophil cytoplasmic antibody-positive subgroup.
Duerr RH; Neigut DA
Gastroenterology; 1995 Feb; 108(2):423-7. PubMed ID: 7835583
[TBL] [Abstract][Full Text] [Related]
11. Ulcerative colitis: a genetically heterogeneous disorder defined by genetic (HLA class II) and subclinical (antineutrophil cytoplasmic antibodies) markers.
Yang H; Rotter JI; Toyoda H; Landers C; Tyran D; McElree CK; Targan SR
J Clin Invest; 1993 Aug; 92(2):1080-4. PubMed ID: 8349790
[TBL] [Abstract][Full Text] [Related]
12. Association of IL-10 and TNFalpha genotypes with ANCA appearance in ulcerative colitis.
Castro-Santos P; Suarez A; Mozo L; Gutierrez C
Clin Immunol; 2007 Jan; 122(1):108-14. PubMed ID: 17070109
[TBL] [Abstract][Full Text] [Related]
13. Are HLA-DR or TAP genes genetic markers of severity in ulcerative colitis?
Heresbach D; Alizadeh M; Reumaux D; Colombel JF; Delamaire M; Danze PM; Gosselin M; Genetet B; Bretagne JF; Semana G
J Autoimmun; 1996 Dec; 9(6):777-84. PubMed ID: 9115580
[TBL] [Abstract][Full Text] [Related]
14. Antineutrophil antibodies define clinical and genetic subgroups in primary sclerosing cholangitis.
Hov JR; Boberg KM; Taraldsrud E; Vesterhus M; Boyadzhieva M; Solberg IC; Schrumpf E; Vatn MH; Lie BA; Molberg Ø; Karlsen TH
Liver Int; 2017 Mar; 37(3):458-465. PubMed ID: 27558072
[TBL] [Abstract][Full Text] [Related]
15. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease.
Satsangi J; Welsh KI; Bunce M; Julier C; Farrant JM; Bell JI; Jewell DP
Lancet; 1996 May; 347(9010):1212-7. PubMed ID: 8622450
[TBL] [Abstract][Full Text] [Related]
16. The presence of anti-neutrophil antibodies reflects clinical and genetic heterogeneity within inflammatory bowel disease.
Satsangi J; Landers CJ; Welsh KI; Koss K; Targan S; Jewell DP
Inflamm Bowel Dis; 1998 Feb; 4(1):18-26. PubMed ID: 9552224
[TBL] [Abstract][Full Text] [Related]
17. Genetic markers linked to rheumatoid arthritis are also strongly associated with articular manifestations in ulcerative colitis patients.
Núñez C; Alecsandru DM; Mendoza JL; Urcelay E; Díaz-Rubio M; de la Concha EG; Martinez A
Hum Immunol; 2006; 67(4-5):324-30. PubMed ID: 16720213
[TBL] [Abstract][Full Text] [Related]
18. Comparative evaluation of unfixed and fixed human neutrophils for determination of antineutrophil cytoplasmic antibodies by indirect immunofluorescence.
Yang P
J Clin Pathol; 1997 Aug; 50(8):677-80. PubMed ID: 9301553
[TBL] [Abstract][Full Text] [Related]
19. HLA antigens and anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease.
García Herola A; Nos P; Hinijosa J; Hoyos M; Molés JR; Carmona E; Puig N; Sánchez-Cuenca JM; Ponce J; Berenguer J
Rev Esp Enferm Dig; 2003 Nov; 95(11):760-4, 755-9. PubMed ID: 14640873
[TBL] [Abstract][Full Text] [Related]
20. Polymorphism of HLA-DRB1 gene shows no strong association with ulcerative colitis in Chinese patients.
Lü M; Xia B
Int J Immunogenet; 2006 Feb; 33(1):37-40. PubMed ID: 16426241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
